Is Angiotensinogen a Hormone: Purity Specifications and Manufacturing Standards in Peptide Sourcing

Core Molecular Specs & Technical Index

Angiotensinogen is a globular glycoprotein primarily synthesized in the liver and secreted into the bloodstream. It serves as the unique precursor to angiotensin I, which is subsequently converted into the potent vasoactive peptide angiotensin II. For B2B buyers in cosmetic formulation and laboratory research, understanding whether angiotensinogen functions as a hormone is critical. While it is not a classical hormone itself, it is the inactive prohormone that initiates the renin-angiotensin system (RAS), making it a pivotal substrate in peptide cascades. Our product is defined by rigorous technical specifications that ensure batch-to-batch consistency for downstream applications.

Basic Properties and Purity Standards

Our angiotensinogen peptide is supplied as a lyophilized powder with a molecular weight of approximately 50–60 kDa, depending on glycosylation patterns. The core purity is guaranteed at ≥98% as determined by reversed-phase high-performance liquid chromatography (RP-HPLC). This high-purity threshold eliminates cross-contamination with other RAS components, which is essential for accurate in vitro studies and formulation stability.

• Purity Level: ≥98% by RP-HPLC, with endotoxin levels below 0.1 EU/µg.
• Solubility: Readily soluble in sterile water or phosphate-buffered saline (PBS) at 1 mg/mL, forming a clear solution without aggregates.
• Storage Conditions: Lyophilized product stable for 24 months at -20°C; reconstituted solution stable for 7 days at 4°C.
• Biological Activity: Verified by renin cleavage assay, demonstrating ≥95% conversion to angiotensin I under standard conditions.
• Glycosylation Profile: Consistent N-glycosylation pattern confirmed by mass spectrometry, ensuring batch reproducibility.

Industry data from the Peptide Therapeutics Foundation indicates that over 70% of peptide research failures stem from inconsistent purity and solubility profiles. Our angiotensinogen product meets the stringent criteria for both academic and commercial R&D environments, reducing variability in experimental outcomes.

Manufacturing & Quality Control

The production of angiotensinogen for B2B sourcing follows a multi-step process that prioritizes structural integrity and functional activity. Unlike small-molecule hormones, angiotensinogen requires careful handling to preserve its tertiary structure and glycosylation sites, which are critical for renin recognition. Our manufacturing standards align with Good Manufacturing Practice (GMP) guidelines for peptide raw materials.

Production Process and Purification

Recombinant angiotensinogen is expressed in a eukaryotic host system to ensure proper post-translational modifications. The fermentation process is monitored in real-time for cell density and protein expression levels. After harvest, the peptide undergoes a series of purification steps including ion-exchange chromatography and size-exclusion chromatography, followed by a final polishing step using RP-HPLC. This yields a product with >98% purity and minimal host cell protein contamination.

Third-Party Testing and Certification

Every batch is subjected to independent third-party analysis to verify identity, purity, and potency. Certificates of Analysis (CoA) are provided with each shipment, detailing results from HPLC, mass spectrometry, and endotoxin testing. Additionally, our facility holds ISO 9001:2015 certification for quality management systems, ensuring traceability from raw material sourcing to final packaging.

• Identity Verification: Mass spectrometry confirms molecular weight within ±0.01% of theoretical value.
• Purity Confirmation: HPLC chromatogram shows a single main peak with no impurities above 0.5%.
• Activity Assay: Renin cleavage test validates functional activity with a coefficient of variation below 5%.
• Sterility Testing: Microbial limits test confirms absence of bacteria, yeast, and mold.
• Stability Data: Accelerated stability studies demonstrate 36-month shelf life at -20°C.

Commercial Application Scenarios

Angiotensinogen is not a hormone in the classical sense, but its role as a prohormone makes it indispensable in both cosmetic and laboratory settings. B2B buyers in these sectors require a reliable supply of high-purity peptide for formulation development and experimental reproducibility.

Cosmetic Formulation

In advanced skincare, angiotensinogen is incorporated into anti-aging serums and creams targeting skin firmness and elasticity. The peptide is used at concentrations of 0.1–1.0% in water-based formulations, where it acts as a substrate for local RAS modulation. Our product’s high solubility and low endotoxin levels make it ideal for sensitive cosmetic applications, ensuring no irritation or contamination in finished goods.

Laboratory Research

Academic and pharmaceutical laboratories utilize angiotensinogen to study hypertension, kidney function, and vascular biology. Researchers require consistent batches to avoid variability in enzyme kinetics and cell-based assays. Our product supports both in vitro and ex vivo experiments, with documented activity that matches native human angiotensinogen.

Bulk Wholesale Usage

For large-scale buyers, we offer bulk packaging from 1 gram to 100 grams, with custom aliquoting options. Bulk orders benefit from reduced per-unit pricing and expedited shipping. Each bulk lot is accompanied by a comprehensive CoA and stability data, enabling seamless integration into production pipelines.

is angiotensinogen a hormone VS Ordinary Low-Grade Peptides

Understanding the distinction between high-quality angiotensinogen and low-grade alternatives is essential for B2B procurement. The table below compares our product with common low-grade peptides found in the market.

Bulk Purchase Selection Guide

When sourcing angiotensinogen in bulk, B2B buyers must navigate common pitfalls to ensure they receive a product that meets their technical requirements. The question "is angiotensinogen a hormone" often leads to confusion about its handling and storage, but the real focus should be on purity and activity specifications.

Common Pitfalls

One frequent mistake is assuming that all angiotensinogen products are equivalent. Low-grade suppliers may offer peptides with inconsistent glycosylation or high endotoxin levels, which compromise both research and formulation outcomes. Another pitfall is neglecting to verify third-party testing documentation, leading to batch failures in downstream processes.

Selection Standards

Buyers should prioritize suppliers that provide full transparency on manufacturing processes and quality control data. Key selection criteria include purity ≥98%, endotoxin levels below 0.1 EU/µg, and documented activity assays. Additionally, confirm that the supplier offers stability data and can accommodate custom packaging for bulk orders.

• Request CoA: Always ask for a Certificate of Analysis from the current batch.
• Verify Activity: Ensure the product includes a renin cleavage assay result.
• Check Storage: Confirm that the supplier maintains cold chain logistics for lyophilized peptides.
• Evaluate Support: Choose a supplier with technical support for formulation or assay troubleshooting.
• Compare Pricing: Factor in purity and activity when comparing per-gram costs.

Core Product Advantages

Our angiotensinogen peptide offers distinct advantages for B2B buyers seeking reliable raw materials for cosmetic and laboratory applications. The combination of high purity, consistent activity, and robust technical support ensures that customers can focus on their core research or product development without supply chain concerns.

Purity: With ≥98% purity by HPLC, our product minimizes interference from impurities, enabling accurate and reproducible results in both formulation and experimental settings.

Stability: Extended shelf life of 36 months at -20°C reduces inventory management challenges and ensures product integrity over time.

Cost Performance: Competitive bulk pricing, combined with high activity levels, delivers superior value compared to alternatives that require higher concentrations to achieve the same effect.

Technical Support: Our team provides application guidance, from reconstitution protocols to formulation compatibility, helping buyers optimize their use of angiotensinogen.

Frequently Asked Questions

Q: Is angiotensinogen a hormone, and how does that affect its use in cosmetics?
A: Angiotensinogen is not a hormone but a prohormone that serves as the precursor to angiotensin I. In cosmetics, it is used as a peptide ingredient that can be incorporated into formulations targeting skin firmness. Its non-hormonal nature means it does not directly exert hormonal effects, making it suitable for topical applications where safety is paramount.

Q: What purity level is required for angiotensinogen in laboratory research?
A: For most laboratory research applications, a purity of ≥98% is recommended to ensure that experimental results are not confounded by impurities. Lower purity peptides may contain degradation products or host cell proteins that interfere with enzyme assays or cell-based studies. Our product meets this standard with full documentation.

Q: How should angiotensinogen be stored to maintain activity during bulk storage?
A: Lyophilized angiotensinogen should be stored at -20°C in a dry, light-protected environment. For bulk quantities, it is advisable to aliquot the peptide into single-use vials to avoid repeated freeze-thaw cycles. Reconstituted solutions should be used within 7 days when stored at 4°C. Our stability data confirms that these conditions preserve activity for up to 36 months.